ArticlePLOS global public health2026
Willingness to accept long-acting injectable antiretroviral therapy among persons living with HIV in a tertiary facility in Southern Ghana: Key consideration for programming.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There a gradual transformation of the HIV epidemic with the emergence of antiretroviral therapy. Adherence to daily pill intake is vital for optimal HIV viral suppression. A strategic approach to enhancing adherence is the development of long-acting injectable ART (LAI-ART). Patients' willingness to accept LAI-ART is a key determinant to the success of these novel therapies, but data is lacking in Africa and Ghana. This study assessed the willingness to accept LAI-ART among patients attending HIV clinic in Accra, Ghana. A cross-sectional study was conducted among 309 patients attending HIV clinic at the Infectious Disease Center of the Korle-Bu Teaching Hospital from July to October 2023. Data on perspectives on LAI-ART was collected using a structured questionnaire. Willingness was measured after exposure to a structured educational session to increase awareness or knowledge on LAI-ART. Descriptive statistics was used to summarize the demographic and clinical characteristics. Bivariate and multivariate analysis was performed with Fisher's exact or Chi square test and logistic regression respectively. Most (71.5%) participants were female, above 50 years (46.3%) and were employed (70.6%). Majority were on a single-pill regimen (80.2%), adherent (86.7%), and had no prior awareness about LAI-ART (69.9%). After structured educational session, 89.6% showed a preference for LAI-ART, with a preferred frequency of injections every 6 months (67.3%). Almost 50% did not prefer self-administration of LAI- ART. Thirty-two percent had concerns about LAI-ART, and about 72% of PLHIV were willing to pay for LAI-ART. Participants' willingness to accept LAI-ART reflected a hypothetical or informed preference and potential acceptability rather than observed behavior due to structured educational session. More education on LAI-ART is needed. LAI- ART presents an opportunity to increase access and adherence to HIV treatment. Further studies assessing potential barriers and how to address them will aid in the success of this treatment regimen.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.